iShares U.S. Healthcare ETF (IYH) Holdings
IYH holdings summary
as of Oct 25, 2026- Holdings
- 99 positions listed
- Top 10 weight
- 58.7% of net assets
- Effective holdings
- 19 equal-weight equivalent
- Largest holding
- LLY 15.20% Eli Lilly and Company
- Annual turnover
- 3.0% of the portfolio traded
Top 1058.7%
Top 2579.8%
Top 5092.2%
All IYH holdings
99 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 15.20% | $685.6M | $1.12T | 42.2 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 9.94% | $448.2M | $615.87B | 38.8 |
| 3 | ABBV | AbbVie Inc. | Healthcare | 7.36% | $332.1M | $504.37B | 80.6 |
| 4 | UNH | UnitedHealth Group Incorporated | Healthcare | 5.53% | $249.3M | $360.32B | 25.8 |
| 5 | MRK | Merck & Co., Inc. | Healthcare | 5.13% | $231.4M | $360.08B | 115.8 |
| 6 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 3.80% | $171.4M | $255.13B | 37.1 |
| 7 | AMGN | Amgen Inc. | Healthcare | 3.54% | $159.6M | $233.82B | 26.9 |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 3.01% | $135.6M | $193.67B | — |
| 9 | PFE | Pfizer Inc. | Healthcare | 2.66% | $119.9M | $168.60B | 38.9 |
| 10 | ABT | Abbott Laboratories | Healthcare | 2.56% | $115.6M | $181.50B | 33.8 |
| 11 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.40% | $108.1M | $150.74B | 48.9 |
| 12 | DHR | Danaher Corporation | Healthcare | 2.13% | $96.2M | $161.01B | 40.8 |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 2.05% | $92.6M | $126.66B | 28.9 |
| 14 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.87% | $84.2M | $122.05B | 13.2 |
| 15 | MDT | Medtronic plc | Healthcare | 1.75% | $79.0M | $121.20B | 23.3 |
| 16 | SYK | Stryker Corporation | Healthcare | 1.59% | $71.9M | $113.02B | 30.5 |
| 17 | ELV | Elevance Health Inc. | Healthcare | 1.42% | $64.3M | $92.88B | 19.0 |
| 18 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.25% | $56.2M | $81.41B | 19.6 |
| 19 | CI | Cigna Corporation | Healthcare | 1.17% | $52.8M | $79.88B | 12.5 |
| 20 | MRNA | Moderna, Inc. | Healthcare | 1.05% | $47.2M | $87.04B | — |
| 21 | BSX | Boston Scientific Corporation | Healthcare | 1.04% | $46.8M | $64.33B | 18.0 |
| 22 | HCA | HCA Healthcare, Inc. | Healthcare | 0.98% | $44.0M | $99.34B | 15.4 |
| 23 | NTRA | Natera, Inc. | Healthcare | 0.82% | $37.0M | $56.71B | — |
| 24 | BDX | Becton, Dickinson and Company | Healthcare | 0.81% | $36.3M | $52.23B | 44.6 |
| 25 | HUM | Humana Inc. | Healthcare | 0.76% | $34.2M | $49.61B | 39.1 |
| 26 | EW | Edwards Lifesciences Corporation | Healthcare | 0.74% | $33.5M | $49.92B | 51.5 |
| 27 | VEEV | Veeva Systems Inc. | Healthcare | 0.74% | $33.2M | $50.25B | 50.9 |
| 28 | A | Agilent Technologies, Inc. | Healthcare | 0.71% | $32.2M | $48.77B | 34.1 |
| 29 | IQV | IQVIA Holdings Inc. | Healthcare | 0.67% | $30.4M | $43.93B | 33.2 |
| 30 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.67% | $30.1M | $44.20B | 39.8 |
| 31 | WAT | Waters Corporation | Healthcare | 0.67% | $30.1M | $42.90B | 110.6 |
| 32 | BIIB | Biogen Inc. | Healthcare | 0.58% | $26.2M | $34.37B | 41.3 |
| 33 | ILMN | Illumina, Inc. | Healthcare | 0.58% | $26.1M | $39.64B | 49.0 |
| 34 | RVMD | Revolution Medicines, Inc. | Healthcare | 0.56% | $25.1M | $38.14B | — |
| 35 | RMD | ResMed Inc. | Healthcare | 0.54% | $24.1M | $33.61B | 22.9 |
| 36 | ZTS | Zoetis Inc. | Healthcare | 0.52% | $23.5M | $32.80B | 13.1 |
| 37 | CNC | Centene Corporation | Healthcare | 0.50% | $22.6M | $34.16B | — |
| 38 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.48% | $21.9M | $31.42B | 16.0 |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 0.44% | $20.0M | $31.02B | 39.1 |
| 40 | DXCM | DexCom, Inc. | Healthcare | 0.42% | $18.8M | $32.47B | 34.1 |
| 41 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.42% | $18.8M | $27.03B | 49.4 |
| 42 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.41% | $18.7M | $25.94B | 24.6 |
| 43 | RPRX | Royalty Pharma plc | Healthcare | 0.39% | $17.6M | $35.22B | 32.4 |
| 44 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.38% | $17.2M | $25.79B | 26.3 |
| 45 | UTHR | United Therapeutics Corporation | Healthcare | 0.37% | $16.5M | $22.87B | 19.1 |
| 46 | STE | STERIS plc | Healthcare | 0.34% | $15.5M | $21.71B | 27.2 |
| 47 | THC | Tenet Healthcare Corporation | Healthcare | 0.33% | $15.0M | $21.52B | 10.5 |
| 48 | GH | Guardant Health, Inc. | Healthcare | 0.32% | $14.5M | $21.28B | — |
| 49 | INSM | Insmed Incorporated | Healthcare | 0.32% | $14.2M | $21.02B | — |
| 50 | VTRS | Viatris Inc. | Healthcare | 0.31% | $14.0M | $21.43B | — |
| 51 | ROIV | Roivant Sciences Ltd. | Healthcare | 0.29% | $12.9M | $24.22B | — |
| 52 | INCY | Incyte Corporation | Healthcare | 0.28% | $12.6M | $22.92B | 14.4 |
| 53 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.27% | $12.3M | $18.12B | 23.1 |
| 54 | RVTY | Revvity, Inc. | Healthcare | 0.27% | $12.1M | $17.03B | 73.0 |
| 55 | EXEL | Exelixis, Inc. | Healthcare | 0.24% | $11.0M | $15.42B | 19.6 |
| 56 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.24% | $10.7M | $14.46B | — |
| 57 | MDLN | Medline Inc. | Healthcare | 0.24% | $10.7M | $48.38B | 89.9 |
| 58 | MEDP | Medpace Holdings, Inc. | Healthcare | 0.23% | $10.3M | $17.26B | 36.3 |
| 59 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 0.22% | $10.1M | $13.83B | 35.6 |
| 60 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.21% | $9.6M | $13.79B | 19.9 |
| 61 | BAX | Baxter International Inc. | Healthcare | 0.20% | $9.2M | $13.07B | — |
| 62 | ASND | Ascendis Pharma A/S | Healthcare | 0.20% | $8.9M | $14.82B | 17.3 |
| 63 | SOLV | Solventum Corporation | Healthcare | 0.20% | $8.9M | $14.61B | 10.5 |
| 64 | EHC | Encompass Health Corporation | Healthcare | 0.19% | $8.7M | $12.61B | 21.4 |
| 65 | PEN | Penumbra, Inc. | Healthcare | 0.19% | $8.4M | $12.64B | 78.8 |
| 66 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 0.18% | $8.3M | $13.65B | 14.4 |
| 67 | COO | The Cooper Companies, Inc. | Healthcare | 0.18% | $8.0M | $11.02B | 19.9 |
| 68 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.17% | $7.9M | $12.98B | — |
| 69 | TECH | Bio-Techne Corporation | Healthcare | 0.17% | $7.5M | $11.38B | 62.6 |
| 70 | AVTR | Avantor, Inc. | Healthcare | 0.17% | $7.5M | $11.11B | — |
| 71 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.16% | $7.4M | $10.58B | 147.8 |
| 72 | MOH | Molina Healthcare, Inc. | Healthcare | 0.16% | $7.3M | $10.82B | — |
| 73 | ELAN | Elanco Animal Health Incorporated | Healthcare | 0.16% | $7.2M | $11.76B | — |
| 74 | RGEN | Repligen Corporation | Healthcare | 0.16% | $7.1M | $11.14B | 240.3 |
| 75 | ALGN | Align Technology, Inc. | Healthcare | 0.15% | $7.0M | $10.46B | 25.6 |
| 76 | QGEN | Qiagen N.V. | Healthcare | 0.15% | $6.9M | $9.53B | 23.4 |
| 77 | CORT | Corcept Therapeutics Incorporated | Healthcare | 0.15% | $6.9M | $11.91B | 244.8 |
| 78 | PODD | Insulet Corporation | Healthcare | 0.15% | $6.7M | $9.79B | 26.4 |
| 79 | ENSG | The Ensign Group, Inc. | Healthcare | 0.14% | $6.5M | $10.29B | 27.7 |
| 80 | UHS | Universal Health Services, Inc. | Healthcare | 0.14% | $6.1M | $10.91B | 7.6 |
| 81 | GMED | Globus Medical, Inc. | Healthcare | 0.13% | $5.9M | $10.30B | 19.7 |
| 82 | HSIC | Henry Schein, Inc. | Healthcare | 0.12% | $5.6M | $9.63B | 25.2 |
| 83 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 0.12% | $5.2M | $10.39B | — |
| 84 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 0.11% | $5.1M | $7.90B | — |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.10% | $4.6M | $7.14B | — |
| 86 | CHE | Chemed Corporation | Healthcare | 0.10% | $4.4M | $6.70B | 25.8 |
| 87 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | 0.10% | $4.4M | $9.46B | 44.8 |
| 88 | TEM | Tempus AI, Inc. | Healthcare | 0.10% | $4.3M | $11.68B | — |
| 89 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.10% | $4.3M | $8.23B | — |
| 90 | TFX | Teleflex Incorporated | Healthcare | 0.09% | $4.2M | $5.53B | — |
| 91 | DVA | DaVita Inc. | Healthcare | 0.09% | $4.2M | $11.95B | 15.8 |
| 92 | BRKR | Bruker Corporation | Healthcare | 0.09% | $4.2M | $8.35B | — |
| 93 | SHC | Sotera Health Company | Healthcare | 0.08% | $3.5M | $5.11B | 31.4 |
| 94 | DOCS | Doximity, Inc. | Healthcare | 0.06% | $2.7M | $5.52B | 36.4 |
| 95 | CAI | Caris Life Sciences, Inc. | Healthcare | 0.06% | $2.6M | $8.64B | 18.1 |
| 96 | NVST | Envista Holdings Corporation | Healthcare | 0.06% | $2.6M | $3.68B | 39.5 |
| 97 | OGN | Organon & Co. | Healthcare | 0.05% | $2.4M | $3.61B | 17.6 |
| 98 | VKTX | Viking Therapeutics, Inc. | Healthcare | 0.05% | $2.1M | $3.20B | — |
| 99 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.03% | $1.4M | $11.67B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($4.51B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
IYH sector breakdown
Sum of the weights of the holdings in each sector.
IYH top industries
Drug Manufacturers - General
49.3%
Diagnostics & Research
12.1%
Medical Devices
9.9%
Healthcare Plans
9.5%
Biotechnology
8.7%
Medical Instruments & Supplies
5.6%
Medical Care Facilities
2.0%
Drug Manufacturers - Specialty & Generic
1.6%
Health Information Services
0.9%
Medical Distribution
0.1%
IYH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 90.6% | 55 of 60 | 0.09% |
| TRUH | VanEck Healthcare TruSector ETF | 90.3% | 55 of 60 | — |
| FHLC | Fidelity MSCI Health Care ETF | 87.9% | 97 of 334 | 0.07% |
| VHT | Vanguard Health Care ETF | 87.2% | 95 of 406 | 0.10% |
| IXJ | iShares Global Healthcare ETF | 68.5% | 55 of 106 | 0.42% |
| PBPH | Portfolio Building Block World Pharma and… | 59.6% | 29 of 52 | — |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the IYH portfolio
iShares U.S. Healthcare ETF holds 99 positions. The ten largest make up 58.7% of the fund and the top 50 92.2%, so it behaves like a portfolio of about 19 equally weighted stocks. The biggest positions are Eli Lilly and Company (15.20%), Johnson & Johnson (9.94%), AbbVie Inc. (7.36%), UnitedHealth Group Incorporated (5.53%), Merck & Co., Inc. (5.13%).
By sector, Healthcare is 99.7%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: IYH chart, IYH performance, IYH dividends, IYH valuation, IYH overview.
IYH holdings FAQ
How many holdings does IYH have?
IYH holds 99 positions as of October 25, 2026.
What are the top 10 holdings of IYH?
The ten largest holdings are Eli Lilly and Company (15.20%), Johnson & Johnson (9.94%), AbbVie Inc. (7.36%), UnitedHealth Group Incorporated (5.53%), Merck & Co., Inc. (5.13%), Thermo Fisher Scientific Inc. (3.80%), Amgen Inc. (3.54%), Gilead Sciences, Inc. (3.01%), Pfizer Inc. (2.66%), Abbott Laboratories (2.56%). Together they are 58.7% of the fund.
What percentage of IYH is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 15.20% of net assets, about $685.6M of the fund's $4.51B.
How concentrated is IYH?
The top 10 holdings are 58.7% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) IYH behaves like a portfolio of about 19 equally weighted stocks.